Astria Therapeutics Inc News

JMP Securities Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsFeb 18 10:31 ET

Astria Therapeutics Initiated at Market Outperform by JMP Securities

Dow JonesJan 31 12:10 ET

JMP Securities Initiates Astria Therapeutics Inc(ATXS.US) With Buy Rating, Announces Target Price $26

Moomoo NewsJan 31 01:32 ET

H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsJan 23 10:31 ET

Evercore Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsJan 16 08:31 ET

LifeSci Capital Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Cuts Target Price to $22

Moomoo NewsJan 14 08:31 ET

Oppenheimer Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $32

Moomoo NewsJan 14 08:31 ET

Astria Therapeutics Analyst Ratings

BenzingaJan 13 10:46 ET

H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsJan 13 10:31 ET

LifeSci Capital Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsDec 11, 2024 15:31 ET

H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsDec 11, 2024 12:31 ET

Oppenheimer Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Raises Target Price to $32

Moomoo NewsDec 11, 2024 12:31 ET

Astria Therapeutics Analyst Ratings

BenzingaDec 10, 2024 12:16 ET

H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsDec 10, 2024 10:31 ET

TD Cowen Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsNov 20, 2024 07:33 ET

A Quick Look at Today's Ratings for Astria Therapeutics Inc(ATXS.US), With a Forecast Between $23 to $35

Moomoo NewsNov 15, 2024 08:03 ET

Astria Therapeutics Analyst Ratings

BenzingaNov 14, 2024 08:18 ET

H.C. Wainwright Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsNov 14, 2024 06:31 ET

LifeSci Capital Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsOct 24, 2024 15:31 ET

Astria Therapeutics Analyst Ratings

BenzingaSep 27, 2024 06:40 ET